|
US3528960A
(en)
|
1968-10-07 |
1970-09-15 |
Lilly Co Eli |
N-carboxyaroyl insulins
|
|
US3869437A
(en)
|
1970-05-08 |
1975-03-04 |
Nat Res Dev |
Mono-, di, and N{HD A1{B , N{HU B1{B , N{HU B29{B -tri-acylated insulin
|
|
GB1381274A
(en)
|
1971-01-28 |
1975-01-22 |
Nat Res Dev |
Insulin derivatives
|
|
US3864325A
(en)
|
1971-11-18 |
1975-02-04 |
Nat Res Dev |
(N{HU Al{b , N{HU Bl{b , N{HU B29{B , carbamoyl)-(O{HU A14{B , O{HU B16{B , O{HU B26{B aryl) insulin derivatives
|
|
JPH01254699A
(ja)
|
1988-04-05 |
1989-10-11 |
Kodama Kk |
インスリン誘導体及びその用途
|
|
KR910700262A
(ko)
*
|
1988-12-23 |
1991-03-14 |
안네 제케르 |
사람 인슐린 유사체
|
|
JP3122128B2
(ja)
*
|
1989-12-21 |
2001-01-09 |
ノボ ノルディスク アクティーゼルスカブ |
ペプチド製剤
|
|
US6011007A
(en)
|
1993-09-17 |
2000-01-04 |
Novo Nordisk A/S |
Acylated insulin
|
|
CZ287945B6
(cs)
|
1993-09-17 |
2001-03-14 |
Novo Nordisk A/S |
Inzulinový derivát a farmaceutický prostředek s jeho obsahem pro léčení diabetu
|
|
US6869930B1
(en)
|
1993-09-17 |
2005-03-22 |
Novo Nordisk A/S |
Acylated insulin
|
|
US6703017B1
(en)
*
|
1994-04-28 |
2004-03-09 |
Ixion Biotechnology, Inc. |
Reversal of insulin-dependent diabetes by islet-producing stem cells, islet progenitor cells and islet-like structures
|
|
US5461031A
(en)
|
1994-06-16 |
1995-10-24 |
Eli Lilly And Company |
Monomeric insulin analog formulations
|
|
US5646242A
(en)
|
1994-11-17 |
1997-07-08 |
Eli Lilly And Company |
Selective acylation of epsilon-amino groups
|
|
US5693609A
(en)
|
1994-11-17 |
1997-12-02 |
Eli Lilly And Company |
Acylated insulin analogs
|
|
US6251856B1
(en)
|
1995-03-17 |
2001-06-26 |
Novo Nordisk A/S |
Insulin derivatives
|
|
PL183698B1
(pl)
|
1995-03-17 |
2002-06-28 |
Novo Nordisk As |
Pochodna insuliny, kompozycja farmaceutyczna i zastosowanie pochodnej insuliny
|
|
US6451970B1
(en)
|
1996-02-21 |
2002-09-17 |
Novo Nordisk A/S |
Peptide derivatives
|
|
US5905140A
(en)
|
1996-07-11 |
1999-05-18 |
Novo Nordisk A/S, Novo Alle |
Selective acylation method
|
|
US5898067A
(en)
|
1997-02-07 |
1999-04-27 |
Novo Nordisk A/S |
Crystallization of proteins
|
|
ES2260832T3
(es)
|
1997-03-20 |
2006-11-01 |
Novo Nordisk A/S |
Cristales de insulina desprovistos de zinc utilizados en composiciones pulmonares.
|
|
CN1240718C
(zh)
|
1997-10-24 |
2006-02-08 |
诺沃挪第克公司 |
人胰岛素衍生物的聚集体
|
|
US6451762B1
(en)
|
1997-10-24 |
2002-09-17 |
Novo Nordisk A/S |
Aggregates of human insulin derivatives
|
|
US6444641B1
(en)
|
1997-10-24 |
2002-09-03 |
Eli Lilly Company |
Fatty acid-acylated insulin analogs
|
|
EA200000453A1
(ru)
|
1997-10-24 |
2000-10-30 |
Эли Лилли Энд Компани |
Композиции нерастворимого инсулина
|
|
ZA989744B
(en)
|
1997-10-31 |
2000-04-26 |
Lilly Co Eli |
Method for administering acylated insulin.
|
|
US6531448B1
(en)
|
1997-12-23 |
2003-03-11 |
Eli Lilly And Company |
Insoluble compositions for controlling blood glucose
|
|
EP1044016B1
(en)
|
1998-01-09 |
2005-03-16 |
Novo Nordisk A/S |
Stabilised insulin compositions
|
|
EP1086130A1
(en)
|
1998-06-12 |
2001-03-28 |
Kings College London |
Insulin analogue
|
|
WO2001000675A1
(en)
|
1999-06-29 |
2001-01-04 |
Eli Lilly And Company |
Protamine-free insoluble acylated insulin compositions
|
|
AU2001264789A1
(en)
|
2000-06-08 |
2001-12-17 |
Eli Lilly And Company |
Protein powder for pulmonary delivery
|
|
DE10114178A1
(de)
|
2001-03-23 |
2002-10-10 |
Aventis Pharma Gmbh |
Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
|
|
EP1453860A2
(en)
|
2001-12-02 |
2004-09-08 |
Novo Nordisk A/S |
Novel glucose-dependant insulins
|
|
PL374949A1
(en)
|
2001-12-20 |
2005-11-14 |
Eli Lilly And Company |
Insulin molecule having protracted time action
|
|
US8003605B2
(en)
|
2002-03-13 |
2011-08-23 |
Novo Nordisk A/S |
Minimising body weight gain in insulin treatment
|
|
US20040138099A1
(en)
|
2002-11-29 |
2004-07-15 |
Draeger Eberhard Kurt |
Insulin administration regimens for the treatment of subjects with diabetes
|
|
US20060217290A1
(en)
|
2003-04-29 |
2006-09-28 |
Kohn Wayne D |
Insulin analogs having protracted time action
|
|
US20060183667A1
(en)
|
2003-07-11 |
2006-08-17 |
Novo Nordisk A/S |
Stabilised insulin compositions
|
|
WO2005005477A2
(en)
|
2003-07-11 |
2005-01-20 |
Novo Nordisk A/S |
Stabilised insulin compositions
|
|
MXPA06001283A
(es)
|
2003-08-05 |
2006-04-11 |
Novo Nordisk As |
Derivados de insulina novedosos.
|
|
KR101152470B1
(ko)
|
2003-08-13 |
2012-06-01 |
바이오콘 리미티드 |
치료제용 마이크로-입자 지방산 염 고형 투약 제형
|
|
EP1687428A1
(en)
|
2003-11-14 |
2006-08-09 |
Novo Nordisk A/S |
Processes for making acylated insulin
|
|
CN1902226A
(zh)
|
2003-12-03 |
2007-01-24 |
诺和诺德公司 |
单链胰岛素
|
|
WO2006008238A1
(en)
|
2004-07-16 |
2006-01-26 |
Novo Nordisk A/S |
Method for selective acylation
|
|
BRPI0513508B1
(pt)
|
2004-07-19 |
2021-06-01 |
Biocon Limited |
Conjugados de insulina-oligômero, formulações e usos desses
|
|
WO2006082204A1
(en)
|
2005-02-02 |
2006-08-10 |
Novo Nordisk A/S |
Insulin derivatives
|
|
EP1846447B1
(en)
|
2005-02-02 |
2013-08-21 |
Novo Nordisk A/S |
Insulin derivatives
|
|
EP1863840A1
(en)
|
2005-03-18 |
2007-12-12 |
Novo Nordisk A/S |
Pegylated single-chain insulin
|
|
JP4808785B2
(ja)
|
2005-12-28 |
2011-11-02 |
ノボ・ノルデイスク・エー／エス |
インスリン組成物および組成物の製造方法
|
|
EP1991576B1
(en)
|
2006-02-27 |
2010-09-29 |
Novo Nordisk A/S |
Insulin derivatives
|
|
MX2008014061A
(es)
|
2006-05-09 |
2008-11-14 |
Novo Nordisk As |
Derivado de insulina.
|
|
EP2024390B1
(en)
|
2006-05-09 |
2015-08-19 |
Novo Nordisk A/S |
Insulin derivative
|
|
EP2076242B8
(en)
|
2006-07-27 |
2013-02-20 |
Nektar Therapeutics |
Aerosolizable formulation comprising insulin for pulmonary delivery
|
|
ES2542146T3
(es)
|
2006-07-31 |
2015-07-31 |
Novo Nordisk A/S |
Insulinas extendidas PEGiladas.
|
|
DK2074141T3
(en)
*
|
2006-09-22 |
2016-11-28 |
Novo Nordisk As |
The protease resistant insulin analogues.
|
|
WO2008145721A2
(en)
|
2007-06-01 |
2008-12-04 |
Novo Nordisk A/S |
N-terminal modification of polypeptides for protection against degradation by aminopeptidases
|
|
US9034818B2
(en)
|
2007-06-13 |
2015-05-19 |
Novo Nordisk A/S |
Pharmaceutical formulations comprising an insulin derivative
|
|
WO2009015456A1
(en)
|
2007-07-30 |
2009-02-05 |
Generex Pharmaceuticals Inc. |
Pharmaceutical formulation in mixed micellar form and dispenser for oral delivery of agents as a spray
|
|
KR20100053561A
(ko)
|
2007-08-15 |
2010-05-20 |
노보 노르디스크 에이/에스 |
아실 및 알킬렌 글리콜 부분을 갖는 인슐린 유사체
|
|
US8710000B2
(en)
|
2007-11-08 |
2014-04-29 |
Novo Nordisk A/S |
Insulin derivative
|
|
JP5241849B2
(ja)
|
2007-11-16 |
2013-07-17 |
ノボ・ノルデイスク・エー／エス |
インスリン及びインスリン分泌性ペプチドを含む薬学的組成物
|
|
MX2010005317A
(es)
|
2007-11-20 |
2010-06-02 |
Ambrx Inc |
Polipeptidos de insulina modificados y sus usos.
|
|
WO2009112583A2
(en)
*
|
2008-03-14 |
2009-09-17 |
Novo Nordisk A/S |
Protease-stabilized insulin analogues
|
|
CN102037008B
(zh)
*
|
2008-03-18 |
2016-08-31 |
诺沃-诺迪斯克有限公司 |
蛋白酶稳定化的、酰化胰岛素类似物
|
|
US8637647B2
(en)
|
2008-09-12 |
2014-01-28 |
Novo Nordisk A/S |
Method of acylating a peptide or protein
|
|
AU2009309623B9
(en)
|
2008-10-30 |
2014-10-02 |
Novo Nordisk A/S |
Treating diabetes melitus using insulin injections with less than daily injection frequency
|
|
WO2010080609A1
(en)
|
2008-12-19 |
2010-07-15 |
Indiana University Research And Technology Corporation |
Amide-based insulin prodrugs
|
|
WO2011000823A1
(en)
|
2009-06-30 |
2011-01-06 |
Novo Nordisk A/S |
Insulin derivatives
|
|
PL2459171T3
(pl)
*
|
2009-07-31 |
2017-11-30 |
Sanofi-Aventis Deutschland Gmbh |
Kompozycja insuliny o długim działaniu
|
|
US20130143803A1
(en)
|
2010-05-10 |
2013-06-06 |
Novo Nordisk A/S |
Process for the Preparation of Insulin-Zinc Complexes
|
|
EP2585484A1
(en)
|
2010-06-23 |
2013-05-01 |
Novo Nordisk A/S |
Insulin analogues containing additional disulfide bonds
|
|
RU2598273C2
(ru)
*
|
2010-06-23 |
2016-09-20 |
Ново Нордиск А/С |
Производные инсулина, содержащие дополнительные дисульфидные связи
|
|
EP2595647A1
(en)
|
2010-07-20 |
2013-05-29 |
Novo Nordisk A/S |
N-terminal modified fgf21 compounds
|
|
CN103596584B
(zh)
*
|
2011-06-15 |
2016-12-14 |
诺沃—诺迪斯克有限公司 |
多取代的胰岛素
|
|
JP2014533241A
(ja)
|
2011-10-27 |
2014-12-11 |
ケース ウェスタン リザーブ ユニバーシティＣａｓｅ Ｗｅｓｔｅｒｎｒｅｓｅｒｖｅ Ｕｎｉｖｅｒｓｉｔｙ |
超濃縮速効型インスリン類似体製剤
|